Enhanced transdermal permeability of piroxicam through novel nanoemulgel formulation

ABSTRACT

Background: Piroxicam is a non-steroidal anti-infl ammatory drug belongs to BCS class II drugs having poor solubility and is associated with a number of undesirable side-effects on the stomach and kidneys in addition to gastric mucosal damage. Aim: The present work was to develop and characterize nanoemulgel formulation as transdermal delivery system for poorly water soluble drug, in order to overcome the troubles associated with its oral delivery and to circumvent the need of chemical penetration enhancers, which are responsible for causing skin irritation in transdermal drug delivery.Materials and Methods:Different nanoemulsion components (oil, surfactant and co-surfactant) were selected on the basis of solubility and emulsifi cation ability. Pseudoternary phase diagrams were constructed using aqueous titration method to fi gure out the concentration range of components. Carbopol 934 was added as gel matrix to convert nanoemulsion into nanoemulgel. Drug loaded nanoemulsions and nanoemulgels were characterized for particle size, transmission electron microscopy, viscosity, conductivity, spreadability, rheological behavior, permeation studies using Wistar rat skin and stability studies. Transdermal permeation of piroxicam from nanoemulgels was determined by using Franz Diffusion cell. Results:The optimized nanoemulgel (BG6) contained 10% oleic acid as oil, 35% tween 80 and ethanol as surfactant co-surfactant mixture, 55% water, 0.5% drug and 0.5% w/w carbopol. The ex vivo permeation profi le of optimized formulation was compared with nanoemulsion and marketed formulation (Feldene®). Nanoemulgel showed higher (P < 0.05) cumulative amount of drug permeated and fl ux and signifi cantly less drug retained along with less lag time than marketed formulation. Conclusion:The results indicate that nanoemulgel formulation can be used as a feasible alternative to conventional formulations of piroxicam with advanced permeation characteristics for transdermal application.

KEYWORDS

• Carbopol 934
• nanoemulsion
• permeation
• piroxicam
• ternary diagram

Showing references and in-text citations exactly as published.

• DOI10.4103/2230-973X.133053Copy

RELATED ARTICLES

Matched on section and article type within this issue of IJPI.

• Article · VOLUME 4, ISSUE 2Fast disintegrating crystalline solid dispersions of simvastatin for incorporation into orodispersible tabletsRitesh M Pabari, Asha Jamil, John G Kelly, Zebunnissa Ramtoola · pp. 51–59Original Research ArticleSame type: Article
• Article · VOLUME 4, ISSUE 2Conceptuation, formulation and evaluation of sustained release floating tablets of captopril compression coated with gastric dispersible hydrochlorothiazide using 23 factorial designPathuri Lakshmi Sirisha, Govada Kishore Babu, Puttagunta Srinivasa Babu · pp. 77–87Original Research ArticleSame type: Article
• Article · VOLUME 4, ISSUE 2Novel sustained release and swellable gastroretentive dosage form for ciprofl oxacin hydrochlorideVinay Dhananjay Gaikwad, Vishal Dadasaheb Yadav, Manish Dhananjay Gaikwad · pp. 88–92Original Research ArticleSame type: Article
• Article · VOLUME 4, ISSUE 2Design and optimization of bilayered tablet of Hydrochlorothiazide using the Quality-by-Design approachYatin N Dholariya, Yogesh B Bansod, Rahul M Vora, Sandeep S Mittal, Ajinath Eknath Shirsat, Chandrashekhar L Bhingare · pp. 93–101Original Research ArticleSame type: Article